ENOVIS CORP (ENOV) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ENOV - US1940141062 - Common Stock
22.72 USD
-0.29 (-1.26%)
22.72 USD
0 (0%)
Overall ENOV gets a fundamental rating of 4 out of 10. We evaluated ENOV against 184 industry peers in the Health Care Equipment & Supplies industry. While ENOV is still in line with the averages on profitability rating, there are concerns on its financial health. ENOV may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
- ENOV had positive earnings in the past year.
- ENOV had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: ENOV reported negative net income in multiple years.
- Of the past 5 years ENOV 4 years had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of ENOV (-30.84%) is comparable to the rest of the industry.
- ENOV has a Return On Equity (-67.66%) which is comparable to the rest of the industry.
- With a decent Return On Invested Capital value of 0.12%, ENOV is doing good in the industry, outperforming 64.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -30.84% | ||
| ROE | -67.66% | ||
| ROIC | 0.12% |
ROA(3y)-6.18%
ROA(5y)-3.42%
ROE(3y)-11.19%
ROE(5y)-6.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Operating Margin, with a value of 0.25%, ENOV is in the better half of the industry, outperforming 64.67% of the companies in the same industry.
- ENOV's Operating Margin has declined in the last couple of years.
- The Gross Margin of ENOV (57.19%) is comparable to the rest of the industry.
- ENOV's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.25% | ||
| PM (TTM) | N/A | ||
| GM | 57.19% |
OM growth 3YN/A
OM growth 5Y-43.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y6.07%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENOV is destroying value.
- The number of shares outstanding for ENOV has been increased compared to 1 year ago.
- The number of shares outstanding for ENOV has been increased compared to 5 years ago.
- Compared to 1 year ago, ENOV has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.73, we must say that ENOV is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ENOV (0.73) is comparable to the rest of the industry.
- ENOV has a debt to FCF ratio of 59.72. This is a negative value and a sign of low solvency as ENOV would need 59.72 years to pay back of all of its debts.
- ENOV has a better Debt to FCF ratio (59.72) than 66.85% of its industry peers.
- A Debt/Equity ratio of 0.66 indicates that ENOV is somewhat dependend on debt financing.
- ENOV has a worse Debt to Equity ratio (0.66) than 64.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 59.72 | ||
| Altman-Z | 0.73 |
ROIC/WACC0.01
WACC9.66%
2.3 Liquidity
- A Current Ratio of 2.22 indicates that ENOV has no problem at all paying its short term obligations.
- The Current ratio of ENOV (2.22) is comparable to the rest of the industry.
- ENOV has a Quick Ratio of 1.16. This is a normal value and indicates that ENOV is financially healthy and should not expect problems in meeting its short term obligations.
- ENOV has a worse Quick ratio (1.16) than 69.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
- ENOV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.14%, which is quite impressive.
- Measured over the past years, ENOV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.18% on average per year.
- Looking at the last year, ENOV shows a quite strong growth in Revenue. The Revenue has grown by 11.57% in the last year.
- ENOV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.73% yearly.
EPS 1Y (TTM)26.14%
EPS 3Y-23.78%
EPS 5Y-16.18%
EPS Q2Q%2.74%
Revenue 1Y (TTM)11.57%
Revenue growth 3Y13.9%
Revenue growth 5Y-8.73%
Sales Q2Q%8.65%
3.2 Future
- Based on estimates for the next years, ENOV will show a very strong growth in Earnings Per Share. The EPS will grow by 23.19% on average per year.
- ENOV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.87% yearly.
EPS Next Y14.57%
EPS Next 2Y11.17%
EPS Next 3Y11.67%
EPS Next 5Y23.19%
Revenue Next Year7.37%
Revenue Next 2Y5.98%
Revenue Next 3Y6.01%
Revenue Next 5Y8.87%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 6.82, which indicates a rather cheap valuation of ENOV.
- Compared to the rest of the industry, the Price/Earnings ratio of ENOV indicates a rather cheap valuation: ENOV is cheaper than 98.37% of the companies listed in the same industry.
- ENOV is valuated cheaply when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
- The Price/Forward Earnings ratio is 6.50, which indicates a rather cheap valuation of ENOV.
- ENOV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ENOV is cheaper than 98.91% of the companies in the same industry.
- ENOV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 6.82 | ||
| Fwd PE | 6.5 |
4.2 Price Multiples
- 93.48% of the companies in the same industry are more expensive than ENOV, based on the Enterprise Value to EBITDA ratio.
- 72.83% of the companies in the same industry are more expensive than ENOV, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 57.08 | ||
| EV/EBITDA | 8.88 |
4.3 Compensation for Growth
- ENOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.47
PEG (5Y)N/A
EPS Next 2Y11.17%
EPS Next 3Y11.67%
5. Dividend
5.1 Amount
- ENOV does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ENOVIS CORP / ENOV FAQ
What is the ChartMill fundamental rating of ENOVIS CORP (ENOV) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ENOV.
What is the valuation status of ENOVIS CORP (ENOV) stock?
ChartMill assigns a valuation rating of 8 / 10 to ENOVIS CORP (ENOV). This can be considered as Undervalued.
Can you provide the profitability details for ENOVIS CORP?
ENOVIS CORP (ENOV) has a profitability rating of 4 / 10.
What is the earnings growth outlook for ENOVIS CORP?
The Earnings per Share (EPS) of ENOVIS CORP (ENOV) is expected to grow by 14.57% in the next year.